Table of contents

1. Introduction

1.1 Market Definition

1.2 Scope (Inclusion and Exclusions)

1.3 Research & Academic Institutes Assumptions

2. Executive Summary

2.1 Market Overview

2.2 Regional Synopsis

2.3 Competitive Summary

3. Research & Academic Institutes Methodology

3.1 Top-Down Approach

3.2 Bottom-up Approach

3.3. Data Validation

3.4 Primary Interviews

4. Market Dynamics Impact Analysis

4.1 Market Driving Factors Analysis

4.1.1 Drivers

4.1.2 Restraints

4.1.3 Opportunities

4.1.4 Challenges

4.2 PESTLE Analysis

4.3 Porter’s Five Forces Model

5. Statistical Insights and Trends Reporting

5.1 Biologic Drug Prescription Trends, by Region (2023)

5.2 Patient Adherence Rates with On-Body Injectors vs. Traditional Methods (2023)

5.3 Healthcare Spending on Advanced Drug Delivery Devices, by Region (Government, Commercial, Private, Out-of-Pocket), 2023

5.4 Home Healthcare and Self-Administration Trends (2020–2023)

6. Competitive Landscape

6.1 List of Major Companies, By Region

6.2 Market Share Analysis, By Region

6.3 Product Benchmarking

6.3.1 Product specifications and features

6.3.2 Pricing

6.4 Strategic Initiatives

6.4.1 Marketing and Promotional Activities

6.4.2 Distribution and Supply Chain Strategies

6.4.3 Expansion plans and new Product launches

6.4.4 Strategic partnerships and collaborations

6.5 Technological Advancements

6.6 Market Positioning and Branding

7. On-Body Injectors Market Segmentation, by Technology

7.1 Chapter Overview

7.2 Spring-based

7.2.1 Spring-based Market Trends Analysis (2020-2032)

7.2.2 Spring-based Market Size Estimates and Forecasts to 2032 (USD Billion)

7.3 Motor-driven

7.3.1 Motor-driven Market Trends Analysis (2020-2032)

7.3.2 Motor-driven Market Size Estimates and Forecasts to 2032 (USD Billion)

7.4 Rotary Pump

7.4.1 Rotary Pump Market Trends Analysis (2020-2032)

7.4.2 Rotary Pump Market Size Estimates and Forecasts to 2032 (USD Billion)

7.5 Expanding Battery

7.5.1 Expanding Battery Market Trends Analysis (2020-2032)

7.5.2 Expanding Battery Market Size Estimates and Forecasts to 2032 (USD Billion)

7.6 Other

7.6.1 Other Market Trends Analysis (2020-2032)

7.6.2 Other Market Size Estimates and Forecasts to 2032 (USD Billion)

8. On-Body Injectors Market Segmentation, by Application

   8.1 Chapter Overview

  8.2 Oncology

              8.2.1 Oncology Market Trends Analysis (2020-2032)

8.2.2 Oncology Market Size Estimates and Forecasts to 2032 (USD Billion)

  8.3 Diabetes

              8.3.1 Diabetes Market Trends Analysis (2020-2032)

8.3.2 Diabetes Market Size Estimates and Forecasts to 2032 (USD Billion)

8.4 Cardiovascular Disease

              8.4.1 Cardiovascular Disease Market Trends Analysis (2020-2032)

8.4.2 Cardiovascular Disease Market Size Estimates and Forecasts to 2032 (USD Billion)

8.5 Autoimmune Disease

              8.5.1 Autoimmune Disease Market Trends Analysis (2020-2032)

8.5.2 Autoimmune Disease Market Size Estimates and Forecasts to 2032 (USD Billion)

8.6 Others

              8.6.1 Others Market Trends Analysis (2020-2032)

8.6.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)

9. On-Body Injectors Market Segmentation, by End-Use

9.1 Chapter Overview

      9.2 Hospitals & Clinics

             9.2.1 Hospitals & Clinics Market Trends Analysis (2020-2032)

             9.2.2 Hospitals & Clinics Market Size Estimates and Forecasts to 2032 (USD Billion)

      9.3 Home Care Settings

             9.3.1 Home Care Settings Market Trends Analysis (2020-2032)

9.3.2 Home Care Settings Market Size Estimates and Forecasts to 2032 (USD Billion) 

      9.4 Others

             9.4.1 Others Market Trends Analysis (2020-2032)

9.4.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion) 

      10. Regional Analysis

10.1 Chapter Overview

10.2 North America

10.2.1 Trends Analysis

10.2.2 North America On-Body Injectors Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)

10.2.3 North America On-Body Injectors Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion) 

10.2.4 North America On-Body Injectors Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)

10.2.5 North America On-Body Injectors Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)

10.2.6 USA

10.2.6.1 USA On-Body Injectors Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)

10.2.6.2 USA On-Body Injectors Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)

10.2.6.3 USA On-Body Injectors Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)

10.2.7 Canada

10.2.7.1 Canada On-Body Injectors Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)

10.2.7.2 Canada On-Body Injectors Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)

10.2.7.3 Canada On-Body Injectors Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)

10.2.8 Mexico

10.2.8.1 Mexico On-Body Injectors Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)

10.2.8.2 Mexico On-Body Injectors Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)

10.2.8.3 Mexico On-Body Injectors Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)

10.3 Europe

10.3.1 Eastern Europe

10.3.1.1 Trends Analysis

10.3.1.2 Eastern Europe On-Body Injectors Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)

10.3.1.3 Eastern Europe On-Body Injectors Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion) 

10.3.1.4 Eastern Europe On-Body Injectors Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)

10.3.1.5 Eastern Europe On-Body Injectors Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)

10.3.1.6 Poland

10.3.1.6.1 Poland On-Body Injectors Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)

10.3.1.6.2 Poland On-Body Injectors Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)

10.3.1.6.3 Poland On-Body Injectors Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)

10.3.1.7 Romania

10.3.1.7.1 Romania On-Body Injectors Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)

10.3.1.7.2 Romania On-Body Injectors Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)

10.3.1.7.3 Romania On-Body Injectors Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)

10.3.1.8 Hungary

10.3.1.8.1 Hungary On-Body Injectors Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)

10.3.1.8.2 Hungary On-Body Injectors Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)

10.3.1.8.3 Hungary On-Body Injectors Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)

10.3.1.9 turkey

10.3.1.9.1 Turkey On-Body Injectors Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)

10.3.1.9.2 Turkey On-Body Injectors Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)

10.3.1.9.3 Turkey On-Body Injectors Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)

10.3.1.10 Rest of Eastern Europe

10.3.1.10.1 Rest of Eastern Europe On-Body Injectors Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)

10.3.1.10.2 Rest of Eastern Europe On-Body Injectors Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)

10.3.1.10.3 Rest of Eastern Europe On-Body Injectors Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)

10.3.2 Western Europe

10.3.2.1 Trends Analysis

10.3.2.2 Western Europe On-Body Injectors Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)

10.3.2.3 Western Europe On-Body Injectors Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion) 

10.3.2.4 Western Europe On-Body Injectors Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)

10.3.2.5 Western Europe On-Body Injectors Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)

10.3.2.6 Germany

10.3.2.6.1 Germany On-Body Injectors Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)

10.3.2.6.2 Germany On-Body Injectors Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)

10.3.2.6.3 Germany On-Body Injectors Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)

10.3.2.7 France

10.3.2.7.1 France On-Body Injectors Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)

10.3.2.7.2 France On-Body Injectors Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)

10.3.2.7.3 France On-Body Injectors Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)

10.3.2.8 UK

10.3.2.8.1 UK On-Body Injectors Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)

10.3.2.8.2 UK On-Body Injectors Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)

10.3.2.8.3 UK On-Body Injectors Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)

10.3.2.9 Italy

10.3.2.9.1 Italy On-Body Injectors Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)

10.3.2.9.2 Italy On-Body Injectors Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)

10.3.2.9.3 Italy On-Body Injectors Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)

10.3.2.10 Spain

10.3.2.10.1 Spain On-Body Injectors Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)

10.3.2.10.2 Spain On-Body Injectors Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)

10.3.2.10.3 Spain On-Body Injectors Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)

10.3.2.11 Netherlands

10.3.2.11.1 Netherlands On-Body Injectors Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)

10.3.2.11.2 Netherlands On-Body Injectors Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)

10.3.2.11.3 Netherlands On-Body Injectors Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)

10.3.2.12 Switzerland

10.3.2.12.1 Switzerland On-Body Injectors Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)

10.3.2.12.2 Switzerland On-Body Injectors Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)

10.3.2.12.3 Switzerland On-Body Injectors Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)

10.3.2.13 Austria

10.3.2.13.1 Austria On-Body Injectors Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)

10.3.2.13.2 Austria On-Body Injectors Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)

10.3.2.13.3 Austria On-Body Injectors Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)

10.3.2.14 Rest of Western Europe

10.3.2.14.1 Rest of Western Europe On-Body Injectors Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)

10.3.2.14.2 Rest of Western Europe On-Body Injectors Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)

10.3.2.14.3 Rest of Western Europe On-Body Injectors Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)

10.4 Asia Pacific

10.4.1 Trends Analysis

10.4.2 Asia Pacific On-Body Injectors Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)

10.4.3 Asia Pacific On-Body Injectors Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion) 

10.4.4 Asia Pacific On-Body Injectors Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)

10.4.5 Asia Pacific On-Body Injectors Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)

10.4.6 China

10.4.6.1 China On-Body Injectors Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)

10.4.6.2 China On-Body Injectors Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)

10.4.6.3 China On-Body Injectors Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)

10.4.7 India

10.4.7.1 India On-Body Injectors Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)

10.4.7.2 India On-Body Injectors Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)

10.4.7.3 India On-Body Injectors Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)

10.4.8 Japan

10.4.8.1 Japan On-Body Injectors Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)

10.4.8.2 Japan On-Body Injectors Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)

10.4.8.3 Japan On-Body Injectors Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)

10.4.9 South Korea

10.4.9.1 South Korea On-Body Injectors Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)

10.4.9.2 South Korea On-Body Injectors Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)

10.4.9.3 South Korea On-Body Injectors Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)

10.4.10 Vietnam

10.4.10.1 Vietnam On-Body Injectors Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)

10.4.10.2 Vietnam On-Body Injectors Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)

10.4.10.3 Vietnam On-Body Injectors Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)

10.4.11 Singapore

10.4.11.1 Singapore On-Body Injectors Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)

10.4.11.2 Singapore On-Body Injectors Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)

10.4.11.3 Singapore On-Body Injectors Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)

10.4.12 Australia

10.4.12.1 Australia On-Body Injectors Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)

10.4.12.2 Australia On-Body Injectors Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)

10.4.12.3 Australia On-Body Injectors Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)

10.4.13 Rest of Asia Pacific

10.4.13.1 Rest of Asia Pacific On-Body Injectors Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)

10.4.13.2 Rest of Asia Pacific On-Body Injectors Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)

10.4.13.3 Rest of Asia Pacific On-Body Injectors Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)

10.5 Middle East and Africa

10.5.1 Middle East

10.5.1.1 Trends Analysis

10.5.1.2 Middle East On-Body Injectors Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)

10.5.1.3 Middle East On-Body Injectors Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion) 

10.5.1.4 Middle East On-Body Injectors Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)

10.5.1.5 Middle East On-Body Injectors Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)

10.5.1.6 UAE

10.5.1.6.1 UAE On-Body Injectors Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)

10.5.1.6.2 UAE On-Body Injectors Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)

10.5.1.6.3 UAE On-Body Injectors Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)

10.5.1.7 Egypt

10.5.1.7.1 Egypt On-Body Injectors Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)

10.5.1.7.2 Egypt On-Body Injectors Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)

10.5.1.7.3 Egypt On-Body Injectors Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)

10.5.1.8 Saudi Arabia

10.5.1.8.1 Saudi Arabia On-Body Injectors Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)

10.5.1.8.2 Saudi Arabia On-Body Injectors Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)

10.5.1.8.3 Saudi Arabia On-Body Injectors Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)

10.5.1.9 Qatar

10.5.1.9.1 Qatar On-Body Injectors Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)

10.5.1.9.2 Qatar On-Body Injectors Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)

10.5.1.9.3 Qatar On-Body Injectors Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)

10.5.1.10 Rest of Middle East

10.5.1.10.1 Rest of Middle East On-Body Injectors Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)

10.5.1.10.2 Rest of Middle East On-Body Injectors Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)

10.5.1.10.3 Rest of Middle East On-Body Injectors Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)

10.5.2 Africa

10.5.2.1 Trends Analysis

10.5.2.2 Africa On-Body Injectors Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)

10.5.2.3 Africa On-Body Injectors Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion) 

10.5.2.4 Africa On-Body Injectors Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)

10.5.2.5 Africa On-Body Injectors Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)

10.5.2.6 South Africa

10.5.2.6.1 South Africa On-Body Injectors Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)

10.5.2.6.2 South Africa On-Body Injectors Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)

10.5.2.6.3 South Africa On-Body Injectors Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)

10.5.2.7 Nigeria

10.5.2.7.1 Nigeria On-Body Injectors Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)

10.5.2.7.2 Nigeria On-Body Injectors Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)

10.5.2.7.3 Nigeria On-Body Injectors Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)

10.5.2.8 Rest of Africa

10.5.2.8.1 Rest of Africa On-Body Injectors Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)

10.5.2.8.2 Rest of Africa On-Body Injectors Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)

10.5.2.8.3 Rest of Africa On-Body Injectors Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)

10.6 Latin America

10.6.1 Trends Analysis

10.6.2 Latin America On-Body Injectors Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)

10.6.3 Latin America On-Body Injectors Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion) 

10.6.4 Latin America On-Body Injectors Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)

10.6.5 Latin America On-Body Injectors Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)

10.6.6 Brazil

10.6.6.1 Brazil On-Body Injectors Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)

10.6.6.2 Brazil On-Body Injectors Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)

10.6.6.3 Brazil On-Body Injectors Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)

10.6.7 Argentina

10.6.7.1 Argentina On-Body Injectors Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)

10.6.7.2 Argentina On-Body Injectors Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)

10.6.7.3 Argentina On-Body Injectors Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)

10.6.8 Colombia

10.6.8.1 Colombia On-Body Injectors Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)

10.6.8.2 Colombia On-Body Injectors Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)

10.6.8.3 Colombia On-Body Injectors Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)

10.6.9 Rest of Latin America

10.6.9.1 Rest of Latin America On-Body Injectors Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)

10.6.9.2 Rest of Latin America On-Body Injectors Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)

10.6.9.3 Rest of Latin America On-Body Injectors Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)

11. Company Profiles

11.1 West Pharmaceutical Services, Inc.

11.1.1 Company Overview

11.1.2 Financial

11.1.3 Product / Services Offered

11.1.4 SWOT Analysis

11.2 BD (Becton, Dickinson and Company)

11.2.1 Company Overview

11.2.2 Financial

11.2.3 Product / Services Offered

11.2.4 SWOT Analysis

11.3 Stevanato Group

11.3.1 Company Overview

11.3.2 Financial

11.3.3 Product / Services Offered

11.3.4 SWOT Analysis

11.4 Enable Injections

11.4.1 Company Overview

11.4.2 Financial

11.4.3 Product / Services Offered

11.4.4 SWOT Analysis

11.5 Nemera

11.5.1 Company Overview

11.5.2 Financial

11.5.3 Product / Services Offered

11.5.4 SWOT Analysis

11.6 Debiotech SA

             11.6.1 Company Overview

11.6.2 Financial

11.6.3 Product / Services Offered

11.6.4 SWOT Analysis

11.7 AbbVie, Inc.

11.7.1 Company Overview

11.7.2 Financial

11.7.3 Product / Services Offered

11.7.4 SWOT Analysis

11.8 Coherus BioSciences, Inc.

11.8.1 Company Overview

11.8.2 Financial

11.8.3 Product / Services Offered

11.8.4 SWOT Analysis

11.9 Gerresheimer AG

11.9.1 Company Overview

11.9.2 Financial

11.9.3 Product / Services Offered

11.9.4 SWOT Analysis

11.10 E3D Elcam Drug Delivery Devices

11.10.1 Company Overview

11.10.2 Financial

11.10.3 Product / Services Offered

11.10.4 SWOT Analysis

12. Use Cases and Best Practices

13. Conclusion